Huang Lab

David Huang, M.D., Ph.D.

David J. Huang, M.D., Ph.D.
David Huang, M.D., Ph.D.

Dr. David Huang is the Peterson Professor of Ophthalmology and a Professor of Biomedical Engineering at the Oregon Health and Science University (OHSU). Dr. Huang earned his M.D. degree from Harvard University and Ph.D. in Medical Engineering and Medical Physics from Massachusetts Institute of Technology. He received ophthalmology residency training at the Doheny Eye Institute/University of Southern California and fellowship training in cornea, external disease and refractive surgery at Emory University School of Medicine. Prior to joining OHSU, Dr. Huang had been on the faculty of the Cleveland Clinic and the University of Southern California. 

Dr. Huang is known for his innovations in applying laser and optical technology to eye diseases. He is a co-inventor of optical coherence tomography (OCT), an imaging technology that has been applied to the measurement of eye structures with unprecedented precision. More recently he has pioneered anterior segment OCT and OCT angiography. His seminal article on OCT, published in Science in 1991, has been cited more than 10,000 times He has 16 issued patents and 14 pending patents in the areas of OCT, mobile health testing, tissue engineering and corneal laser surgery. He has been the principal investigator of five National Institutes of Health research grants totaling over $20 million.  He has published more than 170 peer-reviewed articles and edited six books. 

David Huang, M.D., Ph.D. receives the Champalimaud Vision Award

David Huang, M.D., Ph.D., was recognized with the Champalimaud Vision Award, the largest prize given for ophthalmic research, for his central role in co-inventing Optical Coherence Tomography. This award was presented to Dr. Huang and his co-authors on September 14, 2012 at a ceremony attended by the President of Portugal and the President of Brazil. The co-authors shared the 1.3 million dollar award.

Other awards Dr. Huang has received include the Jonas Friedenwald Award, one of the highest awards from the Association for Research in Vision & Ophthalmology, and the Senior Achievement Award from the American Academy of Ophthalmology. Dr. Huang leads the Center for Ophthalmic Optics and Lasers. He is a founder of Gobiquity Mobile Health, Inc., a maker of mobile diagnostic apps and devices for medical professionals.

Since its invention, Optical Coherence Tomography has become the most commonly used diagnostic technique in Ophthalmology. It is an extremely versatile technique that is employed in diagnosing and planning treatment of diseases affecting the Cornea, the Retina and Optic Nerve. Its use is essential in managing patients with the most common causes of vision loss and blindness: glaucoma, macular degeneration, and diabetes. In his laboratory at Casey Eye Institute Dr. Huang is currently pioneering new applications of this remarkable technology. These new applications permit the noninvasive visualization of the fine vessels within the eye, and measurement of blood flow in these vessels. This will potentially permit recognition of blinding eye disease prior to the onset of permanent vision loss, and at a time when it is more amenable to treatment.

History and Future of Optical Coherence Tomography (OCT)

David Huang, M.D., Ph.D. of OHSU Casey Eye Institute, discusses the history and future of Optical Coherence Tomography (OCT) from an inventor's perspective.

Career highlights

PowerList 2016. Top 100 most influential people in the world of ophthalmology, #4. The Ophthalmologist 2016.

Faculty Senate Award 2016. Oregon Health &Science University, School of Medicine.


For a complete overview of Dr. Huang's current research and related topics please visit the COOL Lab's site. In addition, detailed information on Dr. Huang's work on Advanced Imaging for Glaucoma can be found on the AIG Study site.